These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24774406)

  • 1. Home subcutaneous infusion of furosemide in advanced decompensated heart failure.
    Sancho-Zamora MA
    Rev Esp Cardiol (Engl Ed); 2014 Mar; 67(3):241-2. PubMed ID: 24774406
    [No Abstract]   [Full Text] [Related]  

  • 2. Home subcutaneous infusion of furosemide in advanced decompensated heart failure. Response.
    Zatarain-Nicolás E; de la Fuente-Galán L; San Román-Calvar JA
    Rev Esp Cardiol (Engl Ed); 2014 Mar; 67(3):242. PubMed ID: 24774407
    [No Abstract]   [Full Text] [Related]  

  • 3. Subcutaneous infusion of furosemide administered by elastomeric pumps for decompensated heart failure treatment: initial experience.
    Zatarain-Nicolás E; López-Díaz J; de la Fuente-Galán L; García-Pardo H; Recio-Platero A; San Román-Calvar JA
    Rev Esp Cardiol (Engl Ed); 2013 Dec; 66(12):1002-4. PubMed ID: 24774118
    [No Abstract]   [Full Text] [Related]  

  • 4. Palliative use of furosemide in continuous subcutaneous infusion in a renal transplant patient with heart failure.
    Picazo Sánchez M; Castillo Lorenzo MN; Cuxart Pérez M; Sans Lorman R
    Nefrologia (Engl Ed); 2018; 38(4):438-439. PubMed ID: 29275931
    [No Abstract]   [Full Text] [Related]  

  • 5. Subcutaneous furosemide for the treatment of heart failure: a state-of-the art review.
    Afari ME; Aoun J; Khare S; Tsao L
    Heart Fail Rev; 2019 May; 24(3):309-313. PubMed ID: 30617666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous Furosemide in Patients With Refractory Heart Failure.
    Lozano Bahamonde A; Escolar Pérez V; Echebarria Chousa A; Azcona Lucio A; Alfambra Vicente S; Rodríguez Rodríguez B
    Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):500-502. PubMed ID: 30029975
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessing parenteral diuretic treatment of decompensated heart failure in the community.
    Austin J; Hockey D; Williams WR; Hutchison S
    Br J Community Nurs; 2013 Nov; 18(11):528, 530-4. PubMed ID: 24471224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous furosemide in patients with refractory heart failure.
    Lozano Bahamonde A; Escolar Pérez V; Laskibar Asua A; Rodríguez Rodríguez M; Murga Eizagaechevarria N
    BMJ Support Palliat Care; 2018 Sep; 8(3):354-355. PubMed ID: 29903849
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous furosemide in decompensated heart failure: do not protocolize dosing but the desired effect!
    de Grooth HJ; Girbes AR; Tuinman PR
    Crit Care; 2014 Dec; 18(6):709. PubMed ID: 25672666
    [No Abstract]   [Full Text] [Related]  

  • 10. Which dosing of furosemide is better in acute decompensated heart failure?
    Jalaba S; Palermo J; Budavari AI
    JAAPA; 2017 Mar; 30(3):11-12. PubMed ID: 28221314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine in acute decompensated heart failure: does left ventricular ejection fraction matter?
    Dalzell JR; Connolly EC
    Int J Cardiol; 2014 Jul; 174(3):739. PubMed ID: 24767136
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial.
    Triposkiadis FK; Butler J; Karayannis G; Starling RC; Filippatos G; Wolski K; Parissis J; Parisis C; Rovithis D; Koutrakis K; Skoularigis J; Antoniou CK; Chrysohoou C; Pitsavos C; Stefanadis C; Nastas J; Tsaknakis T; Mantziari L; Giannakoulas G; Karvounis H; Kalogeropoulos AP; Giamouzis G
    Int J Cardiol; 2014 Mar; 172(1):115-21. PubMed ID: 24485633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal decongestive therapy in acute decompensated heart failure syndromes: far from being solved.
    Núñez J; Núñez E; Bodí V; Bayés-Genís A; Sanchis J
    Int J Cardiol; 2014 Jun; 174(2):457-8. PubMed ID: 24767134
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days.
    Aziz EF; Alviar CL; Herzog E; Cordova JP; Bastawrose JH; Pamidimukala CK; Tojino A; Park TS; Musat D; Kukin M
    Hellenic J Cardiol; 2011; 52(3):227-35. PubMed ID: 21642071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of Subcutaneous Furosemide in Elastomeric Pump vs. Oral Solution for the Treatment of Diuretic Refractory Congestion.
    López-Vilella R; Sánchez-Lázaro I; Husillos Tamarit I; Monte Boquet E; Núñez Villota J; Donoso Trenado V; Martínez Dolz L; Almenar Bonet L
    High Blood Press Cardiovasc Prev; 2021 Nov; 28(6):589-596. PubMed ID: 34596886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Furosemide in acute decompensated heart failure.
    Prescrire Int; 2012 Dec; 21(133):303. PubMed ID: 23373103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of furosemide-mannitol infusion in hospitalized patients with heart failure: an observational single-center cohort study of 122 patients.
    Turagam MK; Velagapudi P; Kalra AS; Ramalingam VS; Sinnakirouchenan R; Holley JL
    Int J Cardiol; 2011 Sep; 151(2):232-4. PubMed ID: 21703703
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study.
    Okuhara Y; Hirotani S; Ando T; Nishimura K; Orihara Y; Komamura K; Naito Y; Mano T; Masuyama T
    Heart Vessels; 2017 Apr; 32(4):419-427. PubMed ID: 27469321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure.
    Trullàs JC; Morales-Rull JL; Casado J; Freitas Ramírez A; Manzano L; Formiga F;
    J Card Fail; 2016 Jul; 22(7):529-36. PubMed ID: 26576715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous Furosemide for Acute Decompensated Congestive Heart Failure: What Is the Evidence?
    Owen DR; MacAllister R; Sofat R
    Clin Pharmacol Ther; 2015 Aug; 98(2):119-21. PubMed ID: 25786394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.